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Renal autacoids are involved in the stimulation of renin gene
expression by low perfusion pressure
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Renal autacoids are involved in the stimulation of renin gene expres-
sion by low perfusion pressure. This study aimed to examine the role of
local autacoids for the regulation of renin secretion and renin gene
expression by the renal perfusion pressure. To this end the effects of
unilateral reduction of renal perfusion by 0.2 mm clips on plasma renin
activity and on renal renin mRNA levels were examined in rats treated
with the cyclooxygenase inhibitor meclofenamate (8 mg/kg body wt, twice
a day), with the NO-synthase inhibitor nitro-L-arginine-methylester (L-
NAME, 40 mg/kg body wt, twice a day) or with a combination of both.
L-NAME alone decreased basal PRA values from 9.9 to 5.4 ng Ang I/hr
x ml, while meclofenamate alone and the combination meclofenamate/
L-NAME had no consistent effect on basal PRA. Unilateral renal artery
clipping increased PRA values from 9.9 ng Ang I/hr X ml to 34, 27, and
16 ng Ang I/hr x ml in vehicle, meclofenamate, and L-NAME treated
animals, respectively, but did not increase PRA in meclofenamate/L-
NAME treated rats (9.5 ng Ang I/hr )< ml). Renal renin mRNA levels in
the clipped kidneys increased 4.8-, 2.6-, 2.5- and 1.8-fold in the clipped
kidneys in vehicle, meclofenamate, L-NAME and mcclofcnamate/L-
NAME injected animals, respectively. These findings indicate that both
the inhibition of prostaglandin synthesis and of the formation of endothc-
hum-derived relaxing factor (EDRF) attenuate the increase of renin gene
expression and of renin secretion in response to acute unilateral renal
hypoperfusion and that the effects of both maneuvers are additive. The
data suggest that the stimulations of renin gene expression in response to
low renal perfusion pressure require both intact prostaglandin and EDRF
formation.
Renin secretion and renin gene expression in the kidneys are
considered to be under the control of a "baroreceptor" mecha-
nism that establishes an inverse relationship between the pressure
in the renal afferent arterioles and the activity of the juxtaglomer-
ular epitheloid cells located in the walls of these vessels [1].
Despite the existence of an attractive stretch-receptor hypothesis
[2] the cellular mechanisms underlying the renal baroreceptor
controlling renin secretion and renin gene expression have not yet
been clarified.
Since not only juxtaglomerular cells but also endothelial cells
are affected by pressure related changes of wall stretch, shear
stress or transmural pressure, it is conceivable that the vascular
endothelial cells could be involved in the baroreceptor function.
In fact, it has been found that hemodynamic parameters such as
shear stress influence the release of endothelial autacoids [3—5].
Moreover, there is evidence that endothelial autacoids such as
prostaglandins or endothelium-derived relaxing factor (EDRF)
could be involved in the control of renin secretion by the renal
perfusion pressure. Thus it has been found that the inhibitors of
EDRF formation attenuate the enhancement of renin secretion in
response to low renal artery pressure both in vivo [61 and in vitro
[7]. The role of prostaglandins in this context is more controver-
sial. While some authors reported that administration of cyclooxy-
genase inhibitors attenuated the rise of renin secretion in re-
sponse to renal artery clamping [8—12], others did not observe
such an effect [13—161.
In view of these findings it appeared reasonable to also consider
a role of endothelial autacoids, such as prostaglandins and EDRF,
for the pressure control of renin gene expression which is yet not
understood. Since renin secretion and renin gene expression can
change nonproportionally [17], the behavior of renin gene expres-
sion cannot be predicted from changes of renin secretion. For the
study of pressure controlled renin gene expression we used the
model of 2 kidney-i clip rats, in which renin gene expression is
markedly stimulated in response to renal flow reduction [18—20].
To assess the role of prostaglandins the animals were treated with
the cyclooxygenase inhibitor meclofenamate, and for investigation
of the role of EDRF the animals were treated with the NO-
synthase inhibitor L-NAME. Our findings suggest that both
prostaglandins and EDRF are required for the enhancement of
renin gene expression in response to low renal perfusion pressure.
Methods
Animals
Male Sprague-Dawley rats weighing 180 to 220 g with free
access to food (Altromin) and tap water were used for the
experiments.
Clipping experiments
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During narcosis with methohexital (50 mg/kg) the left kidney
was exposed by an abdominal incision and sterile silver clips
(Degussa AG, Darmstadt, Germany) with an inner diameter of
0.2 mm were then placed on the left renal arteries. In sham
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clipped animals the left artery was touched only with a forceps.
The animals awaked within 30 minutes after operation and then
drugs were applied by intraperitoneal injection. Nitro-1-arginine-
methylester (L-NAME 40 mg/kg), meclofenamate (8 mg/kg) or
combination of both drugs were used to inhibit NO-synthase
activity, cyclooxygenase activity or both enzymes, respectively.
Drug administration was repeated in 12 hour intervals. Forty-
eight hours after setting the clips rats were killed by decapitation,
blood was collected for detennination of plasma renin activity,
kidneys were rapidly extirpated, weighed, cut in half and frozen in
liquid nitrogen till further processing.
Blood pressure measurement
Arterial blood pressure was measured using a tail cuff method
with a BP recorder 8005 (Rhema, Hofheim, Germany) at 8 a.m.
and 4 p.m. of each experimental day.
Determination of preprorenin mRNA
Total RNA was extracted from the kidneys which were stored at
—70°C, according to the protocol of Chomczynski and Sacchi [211
by homogenization in 10 ml of solution D [guanidine thiocyanate
(4 M) containing 0.5% N-lauryl-sarcosinate, 10 mrvi EDTA, 25 mM
sodium citrate and 700 m'vi /3-mercaptoethanol] with a polytron
homogenizer. Sequentially, 1 ml of 2 M sodium acetate (pH 4), 10
ml of phenol (water saturated) and 2 ml of chloroform were added
to the homogenate, with thorough mixing after addition of each
reagent. After cooling on ice for 15 minutes samples were
centrifuged at 10,000 g for 15 minutes at 4°C. RNA in the
supernatant was precipitated with an equal volume of isopropanol
at —20°C for at least one hour. After centrifugation RNA pellets
were resuspended in 0.5 ml of solution D, again precipitated with
an equal volume of isopropanol at —20°C and RNA pellets were
finally dissolved in diethylpyrocarbonate-treated water and stored
at —80°C till further processing. Renin mRNA was measured by
RNase protection as described recently [22]. A preprorenin
cRNA probe containing 296 base pairs of exon I and II, generated
from a pGEM-4 vector carrying a PstI-KpnI restriction fragment
of a rat preprorenin cDNA [23] was generated by transcription
with SP6 RNA polymerase (Amersham mt., Amersham, UK).
Transcripts were continuously labeled with a32P-GTP (410 Ci!
mmol; Amersham International) and purified on a Sephadex G50
spun column. For hybridization total kidney RNA was dissolved in
a buffer containing 80% formamide, 40 m'vi piperazine-N,N'-
bis(2-ethane sulfonic acid), 400 mrvi NaCl, 1 mivi EDTA (pH 8).
Twenty micrograms of RNA were hybridized in a total volume of
50 p1 at 60°C for 12 hours with 5 X 10 cpm radiolabelled renin
probe. RNase digestion with RNase A and Ti was carried out at
20°C for 30 minutes and terminated by incubation with proteinase
K (0.1 mg!ml) and SDS (0.4%) at 37°C for 30 minutes.
Protected preprorenin mRNA fragments were purified by
phenol/chloroform extraction, ethanol precipitation and subse-
quent electrophoresis on a denaturing 10% polyacrylamide gel.
After autoradiography of the dried gel at —70°C for one to two
days bands representing protected renin mRNA fragments were
excised from the gel and radioactivity was counted with a liquid
scintillation counter (1500 Tri-CarbTm, Packard Instrument
Company, Downers Grove, Illinois, USA). The number of counts
per minute obtained from each sample of total kidney RNA was
expressed relative to an external renin mRNA standard included
in each hybridization consisting of 20 tg pooled RNA extracted
from the 12 kidneys of six normal Sprague-Dawley rats.
Determination of actin mRJ'JA
The abundance of rat cytoplasmatic 13-actin mRNA in total
RNA isolated from the kidneys was determined by RNase pro-
tection assay exactly as described for preprorenin. An actin
cRNA-probe containing the 76 nucleotide first exon and around
200 bp of surrounding sequence was generated by transcription
with SP6 polymerase from a pAMl9 vector carrying a AvaI/
HindIll restriction fragment of actin eDNA [22]. For one assay 2.5
tg RNA were hybridized under the conditions described for the
determination of renin mRNA.
Histology
Animals were anesthetized with methohexital (50 mg/kg) and
perfusion-fixed according to Dawson et al [24]. In brief, animals
were perfused for three minutes via the abdominal aorta at high
pressure. Fixative solution was 0.1 M cacodylate buffer (pH 7.4)
containing 4% hydroxyethyl starch solution, 2.5% paraformalde-
hyde, 0.1% glutaraldehyde, 3 mrvi MgCl and 0.5 g/liter picric acid.
Osmolality was adjusted to 300 mOsm with sucrose. Fixed kidneys
were removed and decapsulated. For light microscopy kidneys
were embedded in paraffin, cut in sections (7 m thick) and
examined at a magnification of 360X.
Plasma renin activity
Plasma renin activity (PRA) was determined utilizing a com-
mercially available radioimmunoassay kit for angiotensin I (Sorin
Biomedica, Düsseldorf, Germany).
Statistics
The ANOVA test was used for interindividual comparisons and
Student's paired f-test for intraindividual comparisons. P < 0.05
was considered significant.
Results
In this study the effects of the cyclooxygenase inhibitor meclofe-
namate and the NO-synthase inhibitor L-NAME were examined
in 2 kidney-i clip rats during decreased renal perfusion pressure
of one kidney. Application of drugs for 48 hours alone and in
combination had no effects on body weights, kidney weights and
total renal RNA contents either in sham clipped animals with
control values of 214 7 g, 1.02 0.03 g and 779 82 g or in
clipped animals with values of 189 3 g, 1.11 0.10 g and 860
75 g for these parameters, respectively.
Effects of L-NAME and meclofenamate in sham clipped animals
Injections of L-NAME significantly increased arterial blood
pressure to 140 12 mm Hg compared to control values of 116
4 mm Hg. Additional injections of meclofenamate reduced this
increase in blood pressure to 128 8 mm Hg which was not
significantly different from control values. Meclofenamate alone
had no effect on arterial blood pressure in sham clipped animals
(Fig. 1A).
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Fig. 1. Blood pressure of nonclipped animals (A) and clipped animals (B)
after injection of vehicle, meclofenamate (8 mg/kg), nitro-L-arginine-methyl-
ester (L-NAME, 40 mg/kg) and combination of meclofenamate and L-
NAME. Open bars represent blood pressure before start of experiments,
hatched bars represent blood pressure at the end of experiments (48 hours
after operation, 1 hour before sacrifice of the animal). Data are means
SEM of 5 animals in each experimental group. *D < 0.05.
Treatment with L-NAME significantly decreased plasma renin
activity by 50%, while meclofenamate and the combination of
meclofenamate with L-NAME did not significantly change plasma
renin activity in nonclipped animals (Fig. 2A). Similarily, L-
NAME treatment significantly decreased renin mRNA levels by
about 15%. In meclofenamate treated animals we also found a
significant reduction of basal renin mRNA levels in the right
kidneys but not in the left kidneys which showed a relatively broad
scatter. The renin mRNA levels in the kidneys of meclofenamate!
L-NAME treated rats also showed a rather broad scatter and were
not different from that found in the vehicle injected animals (Fig.
2B). mRNA levels of the housekeeping gene actin were not
changed by any of the experimental conditions (Fig. 5A panel).
Effects of L-NAME and meclofenamate in clipped animals
Reducing blood flow of renal arteries by 0.2 mm clips increased
arterial blood pressure during injection of vehicle, meclofe-
namate, L-NAME and combination of both drugs to 143 9 mm
Fig. 2. Effect of vehicle (control; 1), meclofenamate (8 mg/kg; 2), nitro-L-
arginine-methylester (L-NAME 40 mg/kg; 3) and combination of meclofe-
namate and L-NAME (4) on plasma renin activity (A) and renin m-RNA
levels (B: hatched bars = right kidneys, open bars = left kidneys) of sham
operated animals. Data are means SEM of 5 animals in each experimental
group. *p < 0.05 versus control values.
Hg, 135 8 mm Hg, 134 10 mm Hg and 128 6 mm Hg,
respectively (Fig. 1B). Clipping of the left renal arteries with 0.2
mm clips increased plasma renin activities in vehicle treated rats
about threefold to 34 ng Ang I/hr X ml. This increase of PRA
values was not significantly reduced to 27 ng Ang I/hr X ml in
meclofenamate treated animals but was significantly attenuated to
16 ng Ang I/hr >< ml in L-NAME injected rats. In animals treated
with a combination of meclofenamate plus L-NAME PRA values
did not increase upon renal artery clipping (Fig. 3A).
Unilateral renal artery clipping increased renal renin mRNA
levels to 420% of the control values in the clipped kidneys and
suppressed renin mRNA levels to 26% of the control value in the
contralateral intact kidneys. The increase of renin mRNA in the
clipped kidneys was attenuated not only by meclofenamate, but
also by L-NAME injections and these drug effects were even
additive. Figure 4 shows a representative autoradiograph of a
renin mRNA protection assay with 20 jg RNA isolated from a
clipped vehicle injected, sham clipped vehicle injected, clipped
meclofenamate injected, clipped L-NAME injected animal, and a
clipped animal injected with the combination of L-NAME and
meclofenaniate. Quantitative evaluation of such autoradiographs
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Renal mRNA levels of actin again were unaffected by all
experimental conditions (Fig. 5B).
Histology of kidneys
To examine if the marked reduction of PRA values and renin
mRNA levels upon renal artery clipping in meclofenamate/L-
NAME treated animals was related to structural changes of the
kidneys, in particular, to damage of the juxtaglomerular appara-
tus, some of the kidneys from vehicle injected, meclofenamate/L-
NAJvIE injected, clipped vehicle injected and clipped meclofe-
namate/L-NAME injected animals were histologically examined.
By normal light epifluorescence no obvious structural differences
were found between clipped and intact kidneys of vehicle and of
meclofenamate/L-NAME injected rats.
Discussion
Fig. 3. A. Plasma renin activity of 2 kidney-i clip rats after two day treatment
with vehicle (control; 1), meclofenamate (8 mg/kg; 2), nitro-L-arginine-
methylester (L-NAME 40mg/kg; 3) and combination of meclofenamate and
L-NAME (4). Dotted line indicates plasma renin activity of vehicle
injected nonclipped animals. Data are means SEM of 5 animals in each
experimental group. *p < 0.05 versus clipped vehicle injected animals. B.
Renin mRNA levels of the right (contralateral) kidneys (hatched bars)
and of the left (clipped) kidneys (open bars) of 2 kidney-i clip rats after
injection of vehicle (control; 1), meclofenamate (8 mg/kg; 2), nitro-L-
arginine-methylester (L-NAME 40 mg/kg; 3) and combination of meclofe-
namate and L-NAME (4). Dotted line indicates renin mRNA levels in
vehicle injected nonclipped animals. Over hatched bars *P < 0.05 versus
contralateral kidneys and over open bars * < 0.05 versus clipped kidneys
of 2 kidney/i clip rats; + P < 0.05 versus clipped animals injected with
one drug only. Data are means SEM of 5 animals in each experimental
group.
shows that in meclofenamate treated rats clipping increased renin
mRNA levels by 1.5-fold over controls in the clipped kidneys, and
decreased renin mRNA levels to 37% of controls in the intact
kidneys. A similar reduction of renin mRNA levels in the clipped
kidneys as with meclofenamate was found in L-NAME injected
animals, in which renin mRNA decreased to 50% of the control
value in the intact kidneys. The strongest reduction of renin
mRNA in the clipped kidneys was found in animals receiving the
combination of meclofenamate plus L-NAME, in which renin
mRNA levels only increased by 0.8-fold. In these animals renin
mRNA in the intact kidney was suppressed to 50% of the control
value (Fig. 3B).
This study was done to examine the requirement of renal
autacoids for the renal baroreceptor mechanism controlling renin
secretion and renin gene expression. Our findings show that
inhibition of EDRF formation leads to an attenuation of basal
renin secretion (Fig. 2A) and to an increase of blood pressure
(Fig. 1A). Inhibition of prostaglandin formation by meclofe-
namate had no consistent effects on basal renin mRNA levels and
on basal plasma renin activities (Fig. 2), suggesting that the overall
role of prostaglandins on basal renin gene expression and on basal
renin secretion is less substantial, The combination of NO-
synthase inhibition and of cyclooxygenase inhibition produced no
decrease of basal renin mRNA levels and basal PRA values (Fig.
2). A possible explanation for this finding could be that L-NAME
alone but not in combination with meclofenamate produced a
significant increase of blood pressure (Fig. 1A), suggesting that
the decreases of PRA values could be related to the increase of
blood pressure induced by L-NAME alone.
More pronounced was the role of renal autacoids in animals
with unilateral renal artery clips. Two days after clipping the
animals had significantly elevated blood pressure in all treatment
groups (Fig. 1B). In vehicle treated animals PRA values increased
from 9.9 to 34 ng Ang I/hr X ml two days after renal artery
clipping. This increase was not significantly attenuated by the
cyclooxygenase inhibitor, but was significantly inhibited by the
NO-synthase inhibitor and was blunted by the combination of
cyclooxygenase with NO-synthase inhibition (Fig. 3A). It appears
therefore as if intact prostaglandin and EDRF formation are
required for the stimulation of renin secretion by low perfusion
pressure. These findings are thus in good accordance with previ-
ous findings showing that either inhibition of prostaglandin for-
mation [8—121 or of EDRF formation [6, 7] only partially inhibit
the rise of renin secretion in response to reduced renal artery
pressure in vivo. It may be suspected that inhibition of prosta-
glandin and of EDRF formation further impairs flow in clipped
kidneys, thus leading to uncontrolled damage of these organs.
This was the reason to also examine the clipped and contralateral
kidneys of animals receiving vehicle or the combination of
meclofenamate with L-NAME on a histological level. There were,
however, no obvious differences in the renal structures between
vehicle and meclofenamate/L-NAME treated rats. In particular,
the renal vasculature and the juxtaglomerular apparatus including
the macula densa appeared to be intact in all kidneys examined.
*
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Fig. 4. Autoradiograph of RNase protection
assay for renin mRNA with 20 ig of total RNA
isolated from a clipped vehicle injected (1), sham
clipped vehicle injected (2), clipped
meclofrnamate injected (3), clipped L-NAME
injected (4) animal, and a clipped animal
injected with the combination of L-NAME and
meclofenamate (5). R = right (contralateral)
kidney, L left (clipped) kidney, St. = 20 g
of RNA standard.
We therefore think that the lack of stimulation of renin secretion
150 in meclofenamate/L-NAME treated animals in response to clip-
ping was due to the lack of prostaglandins and of EDRF rather
than to unspecific damage of the kidneys.
The normal rise of renin mRNA levels in response to clipping
100 was significantly attenuated by both inhibition of prostaglandin or
of EDRF formation. With simultaneous inhibition of prosta-
glandin and of EDRF formation the rise of renin mRNA levels
was almost blunted. We therefore speculate that both intact
prostaglandin and EDRF formation are required for the stimula-
50 tion of renin gene expression in response to renal hypoperfusion.
Our experiments do not distinguish whether the respective effects
of prostaglandins and EDRF are direct on juxtaglomerular cells
or are more indirectly involved. There is evidence that prosta-
glandins [reviewed in 1] and EDRF [25, 26] are direct stimulators
of renin secretion on the level of JG cells. If these in vitro findings
150 can be transferred to the in vivo situation, our findings would
E suggest that prostaglandins and EDRF are required for the
baroreceptor function to produce direct stimulations of renin
secretion and renin gene expression in juxtaglomerular cells. Two
100
principal ways of involvement of prostaglandins and EDRF in the
baroreceptor function are conceivable. Either the release of both
autacoids is inversely related to the perfusion pressure or they are
released in a more pressure independent fashion, implying the
existence of a further pressure-related negative mechanism of
50 renin secretion. While Ehmke et al [27] showed that the release of
prostaglandins was not stimulated by reduction of the perfusion
pressure, the influence of the perfusion pressure on EDRF
release is yet unknown. From results obtained with isolated
arteries [4, 5] one would speculate that an increased endothelial
shear stress produced by an increased perfusion pressure should
increase rather than decrease the release of EDRF. It is also
conceivable that prostaglandins and EDRF relevant for the
baroreceptor function do primarily result form structures different
from endothelial cells such as for instance macula densa cells.
These cells contain high levels of NO-synthase [28, 291, which
could be regulated by the macula densa transport function.
Moreover, direct evidence for a requirement of prostaglandins for
Vehicle Meclof. L-NAME Meclof.
+
L-NAME
Fig. 5. Renal actin mRNA levels in nonclipped animals (A) and clipped
animals (B) after injection of vehicle, mecloftnamate (8 mg/kg twice the
day), L-NAME (40 mg/kg, twice the day) and combination of both dmgs
(meclof + L-NAME). Data are means SEM of 5 animals in each
experimental group. R = right (contralateral) kidney, L = left (clipped)
kidney.
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the macula densa stimulation of renin secretion was provided [30,
31]. Since we have previously obtained evidence that the macula
densa mechanism could be involved in the baroreceptor mecha-
nism [32], it appears not unlikely that macula densa derived
prostaglandins and EDRF could be relevant for the baroreceptor
mechanism. Again, it remains unclear as to whether macula densa
derived autacoids are released in a regulated fashion or provide a
more tonic-like stimulation of juxtaglomerular cells.
Suppression of renin secretion, renin gene expression and renin
content is characteristic for the contralaterals to stenosed kidneys
[18—20]. Our finding that unilateral renal clipping suppressed
renin mRNA levels to about 25% of the control value is in
accordance with these findings. Our findings now show that this
suppression is somewhat relieved during cyclooxygenase and
NO-synthase inhibition, but is still substantial. Even during com-
bination of meclofenamate with L-NAME treatment, a regimen
that prevented a rise of PRA in response to unilateral renal artery
clipping, renin mRNA levels in the contralateral kidneys are still
suppressed to about 50% of the control value. Thus, suppression
of the renin gene in the intact kidney obviously does not require
an increase of systemic PRA and in consequence of Ang IL
Similarily, blood pressure did increase in response to clipping in
meclofenamate/L-NAME treated animals although PRA did not
change. This could suggest that factors different from Ang II are
responsible for the increase of blood pressure and the suppression
of the renin gene in the intact kidney upon unilateral renal artery
stenosis.
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